Adaptin Bio (APTN) Change in Account Payables (2023 - 2026)

Adaptin Bio's Change in Account Payables history runs 4 years deep, the most recent figure standing at -$140781.0 for Q1 2026.

• In Q1 2026, Change in Account Payables rose 79.54% year-over-year to -$140781.0; the TTM figure through Mar 2026 stood at $1.0 million (up 810.26% YoY), while the FY2025 annual figure was $496910.0, down 54.02% from the prior year.
• Change in Account Payables came in at -$140781.0 for Q1 2026 at Adaptin Bio, down from $174014.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $671507.0 in Q3 2025 to a low of -$688124.0 in Q1 2025.
• A 4-year average of $111836.4 and a median of $4250.0 in 2023 frame the typical range for Change in Account Payables.
• On a YoY basis, Change in Account Payables climbed as much as 10241.25% in 2024 and fell as far as 1666.07% in 2024.
• Adaptin Bio's Change in Account Payables stood at $4250.0 in 2023, then surged by 10015.27% to $429899.0 in 2024, then slumped by 59.52% to $174014.0 in 2025, then tumbled by 180.9% to -$140781.0 in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$140781.0, $174014.0, and $671507.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison